
Imagene
AI-powered platform for profiling cancer biomarkers from digitized biopsy images.
About
Imagene provides a SaaS platform powered by its Cross-Modality Intelligence Engine, which analyzes imaging, molecular, and clinical data to discover biomarkers, expand indications, and identify patients. This engine enables biopharma and clinical teams to derive actionable insights for optimizing trial design and improving therapeutic success.
Key facts
At-a-glance profile data
- Website
- imagene-ai.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2020
- Employees
- 38
- Total funding
- $45M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Jul 2025 | Series B | $23M | Larry Ellison |
| 2 May 2022 | Series A | $19M | Larry Ellison |
| 1 Sept 2021 | Seed | $3M | Blumberg Capital |
Tech stack
Detected on imagene-ai.com, last scanned 18 Aug 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- AWS CloudFront
- Hosting
- AWS
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Imagene raised?
Imagene has raised a total of $45M in funding. The most recent round on record is Series B.
How many employees does Imagene have?
Imagene has approximately 38 people on record.
